VF
CTIC

Virtu Financial’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Virtu Financial’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-97,805
Closed -$584K – 2563
2022
Q2 		$584K Buy
+97,805
New +$501K 0.05% 340
2021
Q1 		– Sell
-18,385
Closed -$59K – 2375
2020
Q4 		$59K Buy
+18,385
New +$61.1K 0.01% 1198
2019
Q4 		– Sell
-15,723
Closed -$13K – 2081
2019
Q3 		$13K Buy
15,723
+5,190
+49% +$3.96K ﹤0.01% 1332
2019
Q2 		$9K Buy
+10,533
New +$9.72K ﹤0.01% 1391
2019
Q1 		– Sell
-25,232
Closed -$19K – 2152
2018
Q4 		$19K Buy
25,232
+9,419
+60% +$15.5K ﹤0.01% 1382
2018
Q3 		$34K Sell
15,813
-17,166
-52% -$42.5K ﹤0.01% 1357
2018
Q2 		$164K Sell
32,979
-10,544
-24% -$46.1K 0.01% 1557
2018
Q1 		$170K Buy
+43,523
New +$153K 0.01% 1425
2017
Q4 		– Sell
-16,838
Closed -$54K – 3441
2017
Q3 		$54K Buy
+16,838
New +$56.2K ﹤0.01% 2215
2013
Q3 		– Sell
-8,700
Closed -$91K – 390
2013
Q2 		$91K Buy
+8,700
New +$102K 0.01% 266

Other funds holding CTIC

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Virtu Financial's CTIC Position: Q3 2022 in Review

Virtu Financial sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q3 2022, closing a stake of 97,805 shares — an estimated $584K sold.

Virtu Financial first reported a position in CTIC in Q2 2013 and held it in 10 quarters. The position peaked at $584K in Q2 2022. 133 funds tracked by Wall St. Rank hold CTIC as of Q3 2022.

  • Virtu Financial reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q3 2022 after selling out during the quarter.
  • Virtu Financial sold 97,805 CTI BioPharma Corp. (DE) Common Stock shares in Q3 2022, an estimated $584K.
  • Virtu Financial first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 10 quarters.
  • Virtu Financial's CTI BioPharma Corp. (DE) Common Stock position peaked at $584K in Q2 2022.
  • 133 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q3 2022.

Based on Virtu Financial's 13F filing for Q3 2022, filed 7 Nov 2022.